The Burden of Asthma in Subjects Receiving Low-Dose ICS/LABA - an Analysis from a Real World Survey

被引：0
|
作者：
Gruffydd-Jones, K. [1 ]
Fageras, M. [2 ]
Hamblin, A. [3 ]
Draffan, L. [4 ]
Mestdagh, N. [5 ]
Sidaway, M. [6 ]
Sheikh, A. [7 ]
Small, M. [8 ]
Haq, A. [8 ]
机构：
[1] Warminster Primary Care Ctr, Warminster, PA USA
[2] AstraZeneca, Molndal, Sweden
[3] AstraZeneca, Cambridge, England
[4] Draffan Advisory Serv, Altrincham, England
[5] AstraZeneca, Gothenburg, Sweden
[6] AstraZeneca, Global Med, Molndal, Sweden
[7] Univ Edinburgh, Usher Inst, Coll Med & Vet Med, Edinburgh, Midlothian, Scotland
[8] Adelphi Real World, Bollington, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1314
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Burden of asthma among patients adherent to ICS/LABA: A real-world study
    Davis, Jill
    Trudo, Frank
    Siddall, James
    Small, Mark
    [J]. JOURNAL OF ASTHMA, 2019, 56 (03) : 332 - 340
  • [2] Symptomatic Burden of Asthma Patients Adherent to Medium- or High-Dosage ICS/LABA: Findings From a US Real World Survey
    Trudo, Frank J.
    Davis, Jill R.
    Small, Mark
    Siddall, James
    Pike, James
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB97 - AB97
  • [3] EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
    Buhl, Roland
    Dreher, Michael
    Mattiucci-Guehlke, Muriel
    Emerson-Stadler, Rachel
    Eckhardt, Sebastian
    Taube, Christian
    Vogelmeier, Claus F.
    [J]. ADVANCES IN THERAPY, 2023, 40 (07) : 3263 - 3278
  • [4] EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
    Roland Buhl
    Michael Dreher
    Muriel Mattiucci-Guehlke
    Rachel Emerson-Stadler
    Sebastian Eckhardt
    Christian Taube
    Claus F. Vogelmeier
    [J]. Advances in Therapy, 2023, 40 : 3263 - 3278
  • [5] The disease burden of mild asthma: Findings from a 2013 real world survey
    Ding, Bo
    Small, Mark
    Foden, Harriet
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [6] THE ECONOMIC BURDEN OF ADULT ASTHMA THAT IS UNCONTROLLED ON MEDIUM-TO-HIGH-DOSE ICS-LABA: A SYSTEMATIC LITERATURE REVIEW
    Czira, A.
    Martin, A.
    Turner, M.
    Meeraus, W.
    Birch, H.
    Zhang, S.
    [J]. VALUE IN HEALTH, 2020, 23 : S729 - S729
  • [7] Retrospective Analysis of the Starting Dose of Combined ICS/LABA for Cough-variant Asthma and Cough-predominant Asthma
    Nakajima, Takeo
    Nagano, Tatsuya
    Nishimura, Yoshihiro
    [J]. IN VIVO, 2022, 36 (02): : 949 - 953
  • [8] Analysis of low-dose subgroups receiving NOACs
    Jolobe, O. M. P.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2021, 290 (01) : 220 - 220
  • [9] Six Months Step Down Treatment From High Dose ICS/LABA Combination Therapy In Asthma
    Paggiaro, P.
    Nicolini, G.
    Crimi, N.
    Fabbri, L.
    Olivieri, D.
    Rossi, A.
    Papi, A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [10] AUSTRI and VESTRI LABA Safety studies subgroup analysis of asthma exacerbations and SAEs comparing FSC and FP by ICS dose
    Raphiou, Ibrahim
    Kral, Kenneth
    Brealey, Noushin
    Prillaman, Barbara
    Emmett, Amanda
    Baidoo, Carlotte
    Mancuso, Maria
    Pascoe, Steven
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
12345